Study guide

7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

Key Takeaways Explain This Topic AI

Maternal shock states are classified pathophysiologically into four distinct categories: Hemorrhagic (hypovolemic, driven by massive blood loss), Distributive (septic, anaphylactic, or neurogenic, driven by pathologically reduced systemic vascular resistance), Cardiogenic (pump failure from peripartum cardiomyopathy, myocardial infarction, or myocarditis), and Obstructive (physical impediment to cardiac filling or outflow from massive pulmonary embolism, tension pneumothorax, or cardiac tamponade).

Normal maternal physiology (a 40-50% expansion in blood volume and baseline resting tachycardia) masks early hypovolemic shock; classic signs such as hypotension and marked tachycardia often do not appear until class III hemorrhage (>30% blood volume loss, or >1,500 mL), necessitating reliance on the Shock Index (Heart Rate / Systolic Blood Pressure; SI >=0.9 indicates critical hypoperfusion) for early detection.

Norepinephrine is the first-line vasopressor for septic and distributive shock in pregnancy (titrated to maintain MAP >=65 mmHg to preserve maternal organ and uteroplacental perfusion), whereas Epinephrine is the primary drug of choice for anaphylaxis (0.3 to 0.5 mg IM into the anterolateral thigh) and cardiac arrest, and Dobutamine or Milrinone serve as first-line inotropes for acute cardiogenic shock with preserved blood pressure.

Obstructive shock etiologies represent procedural and surgical emergencies requiring immediate, etiology-specific decompression: emergent needle/finger thoracostomy for tension pneumothorax, urgent bedside subxiphoid pericardiocentesis for cardiac tamponade, and systemic thrombolysis (Alteplase 50 to 100 mg IV) or catheter-directed embolectomy for massive saddle pulmonary embolism with acute right heart strain.

Multimodal hemodynamic assessment—incorporating invasive arterial line monitoring, central venous pressure, point-of-care cardiac and lung ultrasound (POCUS/FoCUS), and advanced non-invasive cardiac output monitoring—is essential to accurately differentiate preload deficiency, contractile failure, systemic vasodilation, and RV outflow obstruction in undifferentiated maternal shock.

Last updated: August 2026

Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

Shock is defined as an acute, life-threatening state of circulatory failure resulting in inadequate cellular oxygen delivery ( D O 2 DO_2 D O 2 ​ ) relative to cellular oxygen consumption ( V O 2 VO_2 V O 2 ​ ). When cellular oxygen demands are unmet, tissues shift from aerobic respiration to anaerobic glycolysis, generating systemic lactic acidosis, cellular dysoxia, ATP depletion, loss of membrane integrity, and progressive multi-organ dysfunction syndrome (MODS).

In pregnant patients, physiological adaptations significantly alter baseline hemodynamic parameters, frequently obscuring classic early signs of shock until sudden, catastrophic decompensation occurs.

  • 1. Pathophysiologic Foundation & The Obstetric Shock Index
  • The Maternal Physiological "Mask"

During pregnancy, maternal blood volume increases by 40% to 50% (approx. 1,500 mL) , baseline cardiac output rises by 30% to 50% , systemic vascular resistance (SVR) decreases, and baseline resting heart rate increases by 10 to 15 bpm.

Because of this hypervolemic reserve, a gravid woman can lose 1,000 to 1,500 mL of blood (up to 30% of total blood volume) before developing overt arterial hypotension (systolic BP <90 mmHg). Compensatory maternal vasoconstriction maintains normal systemic blood pressure while shunting blood away from the uterine circulation. Consequently, fetal distress on fetal monitoring (persistent decelerations, bradycardia) is frequently the earliest indicator of maternal hypoperfusion and occult shock! +---------------------------------------------------------------------------------------------------+

  • | THE OBSTETRIC SHOCK INDEX (SI) |
  • | |
  • | Heart Rate (HR in beats per minute) |
  • | Shock Index (SI) = ---------------------------------------- |
  • | Systolic Blood Pressure (SBP in mmHg) |
  • | |
  • | • Normal Non-Pregnant & Healthy Pregnant Range: **0.5 to 0.7** |
  • | • Mild Elevation / Early Warning Threshold: **0.7 to 0.9** |
  • | • CRITICAL CLINICAL THRESHOLD: **SI >= 0.9** |
  • | - Strongly predicts severe blood loss (>1,500 mL), Massive Transfusion Protocol (MTP) |
  • | activation, intensive care unit (ICU) admission, and emergent surgical intervention. |
  • | • DECOMPENSATED SHOCK THRESHOLD: **SI >= 1.4** |
  • | - Indicates profound circulatory collapse, impending cardiac arrest, and >40% volume loss. |
  • +---------------------------------------------------------------------------------------------------+

2. The Four Major Maternal Shock Taxonomies +---------------------------------------------------------------------------------------------------+

  • | MATERNAL SHOCK CLASSIFICATION MATRIX |
  • | |
  • | 1. HEMORRHAGIC / HYPOVOLEMIC SHOCK: |
  • | • Primary Defect: Depleted intravascular circulating volume (decreased preload). |
  • | • Obstetric Causes: Postpartum hemorrhage (atony 70%, PAS, lacerations, rupture, abruption), |
  • | ectopic pregnancy rupture, subcapsular liver hematoma rupture. |
  • | |
  • | 2. DISTRIBUTIVE SHOCK: |
  • | • Primary Defect: Pathological systemic vasodilation & capillary leak (severely decreased SVR)|
  • | • Obstetric Causes: Septic shock (chorioamnionitis, pyelonephritis, Group A Strep), |
  • | Anaphylactic shock (beta-lactams, latex, iron), Neurogenic shock (high spinal/epidural). |
  • | |
  • | 3. CARDIOGENIC SHOCK: |
  • | • Primary Defect: Primary myocardial contractile / pump failure (severely decreased CI / CO). |
  • | • Obstetric Causes: Peripartum cardiomyopathy (PPCM), Spontaneous coronary artery dissection |
  • | (SCAD), acute myocardial infarction (AMI), myocarditis, severe valvular decompensation. |
  • | |
  • | 4. OBSTRUCTIVE SHOCK: |
  • | • Primary Defect: Physical mechanical barrier to cardiac filling or outflow. |
  • | • Obstetric Causes: Massive pulmonary embolism (PE), tension pneumothorax, cardiac tamponade, |
  • | severe dynamic aortocaval compression. |
  • +---------------------------------------------------------------------------------------------------+
  • A. Hemorrhagic / Hypovolemic Shock in Obstetrics

Obstetric hemorrhage remains the most prevalent cause of maternal shock globally. Staging based on estimated blood loss and hemodynamic parameters guides resuscitation:

Hemorrhage Class Blood Loss (% and mL) Heart Rate (bpm) Blood Pressure Shock Index Mental Status & Urine Output Clinical Action & Transfusion Protocol

Class I <15% (<750–1000 mL) Normal (<100) Normal <0.7 Alert; Normal (>30 mL/hr) Uterotonics, crystalloid maintenance, monitor closely.

Class II (Mild) 15–30% (1000–1500 mL) Mild tachycardia (100–110) Normal / Orthostatic 0.7–0.9 Mild anxiety; 20–30 mL/hr Type & crossmatch, active uterotonics, TXA 1 g IV, prepare blood.

Class III (Moderate) 30–40% (1500–2000 mL) Tachycardia (110–130) Hypotension (SBP <90) 0.9–1.4 Agitated / Confused; Oliguria (5–15 mL/hr) Activate MTP (1:1:1) , Cryoprecipitate, TXA 1 g IV, intrauterine balloon / surgery.

Class IV (Severe) >40% (>2000 mL) Severe (>130 / bradycardia) Profound (<70 mmHg) >1.4 Lethargic / Comatose; Anuria (<5 mL/hr) Emergent surgical hemostasis / Damage control laparotomy / MTP .

  • B. Distributive Shock: Sepsis, Anaphylaxis & Neurogenic
  • 1. Obstetric Septic Shock

Sepsis in pregnancy arises from intra-amniotic infection (chorioamnionitis), postpartum endometritis, acute pyelonephritis, septic abortion, or soft-tissue necrotizing fasciitis (e.g., Streptococcus pyogenes / Group A Strep, Escherichia coli ).

Diagnosis: Validated obstetric screening tools include the Sepsis in Obstetrics Score (S.O.S.) and the Obstetric-Modified Sequential Organ Failure Assessment (omSOFA) score.

Surviving Sepsis Hour-1 Care Bundle:

Measure serum lactate level (re-measure if initial lactate >2 mmol/L).

Obtain blood cultures prior to antibiotic administration (two sets from distinct venipuncture sites).

Administer broad-spectrum empiric IV antibiotics within 1 hour (e.g., Ampicillin-Sulbactam 3 g IV + Gentamicin 5 mg/kg, or Meropenem 1 g IV + Vancomycin 15–20 mg/kg for septic shock).

Rapid IV crystalloid administration: 30 mL/kg of balanced crystalloid (Lactated Ringer's) within the first 3 hours for hypotension or lactate >=4 mmol/L.

Vasopressors: Initiate Norepinephrine infusion to maintain Mean Arterial Pressure (MAP) >=65 mmHg if hypotension persists after initial fluid loading.

2. Maternal Anaphylactic Shock

Anaphylaxis during labor and delivery is commonly triggered by intravenous beta-lactam antibiotics (cefazolin, ampicillin), latex, neuromuscular blocking agents (succinylcholine, rocuronium), intravenous iron infusions, or uterotonics.

Clinical Manifestations: Acute cutaneous signs (urticaria, pruritus, flushing, angioedema) combined with rapid respiratory compromise (stridor, severe bronchospasm) and profound distributive cardiovascular collapse.

First-Line Pharmacological Protocol:

Epinephrine 0.3 to 0.5 mg (0.3 to 0.5 mL of 1:1,000 [1 mg/mL] solution) Intramuscularly (IM) into the anterolateral thigh immediately! Repeat every 5 to 15 minutes if symptoms persist.

Refractory Shock: Initiate continuous IV Epinephrine infusion (0.05 to 0.5 mcg/kg/min).

Secondary Adjuncts (Administer ONLY AFTER Epinephrine): Rapid crystalloid bolus (1–2 L LR), Diphenhydramine 50 mg IV (H1 blocker), Famotidine 20 mg IV (H2 blocker), and Methylprednisolone 125 mg IV.

3. Neurogenic Shock (High / Total Spinal Block)

Occurs from cephalad spread of local anesthetic agents following spinal or epidural administration, blocking sympathetic preganglionic fibers (T1 to L2).

Manifestations: Profound systemic vasodilation and hypotension paired with paradoxical bradycardia (loss of cardiac accelerator fibers T1–T4) and warm, flushed skin.

Management: Rapid crystalloid IV bolus, Left Uterine Displacement, Ephedrine 5 to 10 mg IV boluses (mixed alpha/beta agonist increases both HR and SVR), Phenylephrine 50 to 100 mcg IV (if heart rate is elevated), and Epinephrine 10 to 50 mcg IV if pulseless or profound bradycardia occurs.

C. Cardiogenic Shock in Pregnancy

Cardiogenic shock occurs when primary pump failure results in inadequate forward cardiac output (Cardiac Index <2.2 L/min/m2) despite adequate intravascular volume and ventricular filling pressure (PCWP >15–18 mmHg). +---------------------------------------------------------------------------------------------------+

  • | MAJOR CAUSES OF MATERNAL CARDIOGENIC SHOCK |
  • | |
  • | 1. PERIPARTUM CARDIOMYOPATHY (PPCM): |
  • | • Idiopathic heart failure with Left Ventricular Ejection Fraction (LVEF) <45% presenting |
  • | in the last month of pregnancy or first 5 months postpartum in the absence of prior heart |
  • | disease. Triggered by anti-angiogenic 16-kDa prolactin cleavage fragments (vasoinhibin). |
  • | • Pharmacotherapy: Inotropes (Dobutamine, Milrinone), Bromocriptine (2.5 mg daily for 1-4 wks |
  • | to inhibit prolactin secretion), anticoagulation (high thromboembolism risk when EF <35%). |
  • | |
  • | 2. SPONTANEOUS CORONARY ARTERY DISSECTION (SCAD) & ACUTE MI: |
  • | • Pregnancy hormones and vascular shear stress cause non-atherosclerotic intramural hematoma |
  • | and dissection, predominantly affecting the Left Anterior Descending (LAD) coronary artery. |
  • | • Management: Conservative medical therapy preferred; avoid aggressive stenting unless flow is|
  • | completely occluded. Inotropes and mechanical circulatory support for shock. |
  • | |
  • | 3. ACUTE MYOCARDITIS & DECOMPENSATED VALVULAR DISEASE: |
  • | • Viral myocarditis, severe mitral stenosis with pulmonary edema, or severe aortic stenosis. |
  • +---------------------------------------------------------------------------------------------------+

D. Obstructive Shock: Mechanical Blockades +---------------------------------------------------------------------------------------------------+

  • | OBSTRUCTIVE SHOCK ETIOLOGIES & IMMEDIATE INTERVENTIONS |
  • | |
  • | 1. MASSIVE PULMONARY EMBOLISM (PE): |
  • | • Mechanism: Saddle thrombus occludes >50% of pulmonary arterial tree, triggering acute RV |
  • | dilation, failure, and obstructive cardiogenic collapse. |
  • | • Emergency Treatment: Systemic Thrombolysis (**Alteplase / tPA 50 to 100 mg IV infusion over |
  • | 2 hours**, or 50 mg IV bolus during cardiac arrest) OR catheter-directed thrombectomy. |
  • | |
  • | 2. TENSION PNEUMOTHORAX: |
  • | • Mechanism: Positive intrapleural pressure compresses the lung, shifts the mediastinum, and |
  • | completely collapses the superior and inferior vena cava, abolishing venous return. |
  • | • Emergency Treatment: **Immediate Needle Decompression** (14-gauge catheter in 2nd intercostal|
  • | space midclavicular line or 4th/5th intercostal space anterior axillary line) or emergent |
  • | **Finger Thoracostomy**, followed immediately by 28-32 Fr chest tube thoracostomy. |
  • | |
  • | 3. CARDIAC TAMPONADE: |
  • | • Mechanism: Pericardial fluid under pressure prevents diastolic ventricular filling. |
  • | • Classic Triad (Beck's Triad): Hypotension, Jugular Venous Distension, Muffled Heart Sounds. |
  • | • Emergency Treatment: **Immediate Bedside Ultrasound-Guided Subxiphoid Pericardiocentesis**. |
  • +---------------------------------------------------------------------------------------------------+
  • 3. Comprehensive Hemodynamic Parameter & Profile Comparison

Understanding the distinctive hemodynamic fingerprint of each shock category is essential for making precise clinical diagnoses at the bedside:

Shock Category Preload: RV (CVP) Preload: LV (PCWP) Pump Function: (CO / CI) Afterload: (SVR) Afterload: (PVR) Mixed Venous Oxygen (ScvO2) Primary Pathophysiologic Mechanism & Echo Findings

Hemorrhagic (Hypovolemic) Decreased (<4 mmHg) Decreased (<6 mmHg) Decreased (<2.0 L/min/m2) Increased (>1400 dynes) Normal / Decreased Decreased (<65%) Intravascular volume depletion; compensatory vasoconstriction. Hyperdynamic, small, underfilled ventricles (kissing walls).

Distributive (Septic - Early / Warm) Normal / Decreased Normal / Decreased Increased (>3.5 L/min/m2) Severely Decreased (<600 dynes) Normal Increased (>75–80%) Vasomotor paralysis and endothelial leak; hyperdynamic LV contractility, warm extremities, widened pulse pressure.

Distributive (Late / Cold Sepsis) Variable Variable Decreased (<2.2 L/min/m2) Variable / Normal Increased Decreased (<65%) Myocardial depression and profound capillary leak; cool mottled extremities.

Distributive (Anaphylactic) Decreased Decreased Variable / Decreased Severely Decreased (<500 dynes) Increased (bronchospasm) Decreased Massive histamine/tryptase mediated vasodilation and capillary fluid extravasation.

Cardiogenic (PPCM / MI) Elevated (>12–15 mmHg) Markedly Elevated (>18 mmHg) Severely Decreased (<1.8 L/min/m2) Increased (>1500 dynes) Elevated Severely Decreased (<55%) Primary pump failure; dilated LV, severely reduced ejection fraction (<45%), pulmonary congestion/B-lines.

Obstructive (Massive PE) Markedly Elevated (>15 mmHg) Normal / Decreased (<10 mmHg) Severely Decreased (<1.8 L/min/m2) Increased Severely Elevated (>300 dynes) Decreased (<60%) RV outflow obstruction; massive RV dilation, McConnel's sign, D-sign, underfilled LV.

Obstructive (Tamponade) Markedly Elevated (>15 mmHg) Markedly Elevated (Equalized) Severely Decreased (<1.8 L/min/m2) Increased Normal / Elevated Decreased (<60%) Ventricular diastolic filling restriction; equalized diastolic pressures (CVP = PCWP = RV diastole), swinging heart.

4. Vasoactive & Inotropic Pharmacology in Pregnancy

Selecting vasoactive pharmacotherapy in pregnancy requires balancing maternal hemodynamic stabilization against potential uteroplacental vasoconstriction. Maternal perfusion takes absolute precedence—restoring maternal Mean Arterial Pressure (MAP) is the single most important determinant of uterine blood flow during shock. +---------------------------------------------------------------------------------------------------+

  • | MATERNAL VASOACTIVE & INOTROPIC PHARMACOLOGY |
  • | |
  • | 1. NOREPINEPHRINE (First-Line Vasopressor for Septic / Distributive Shock): |
  • | • Receptor Profile: Alpha-1 (++++), Beta-1 (++), Beta-2 (0). |
  • | • Infusion Dose: 0.02 to 0.5 mcg/kg/min (titrate to MAP >=65 mmHg). |
  • | • Actions: Potent peripheral vasoconstriction restores SVR while modest inotropy preserves CO.|
  • | • Maternal-Fetal Impact: Restoring maternal perfusion pressure increases uteroplacental |
  • | blood flow; first-line drug of choice in maternal septic shock. |
  • | |
  • | 2. EPINEPHRINE (First-Line for Anaphylaxis & Cardiac Arrest; Inotrope in Refractory Shock): |
  • | • Receptor Profile: Beta-1 (++++), Beta-2 (+++), Alpha-1 (++++ at higher doses). |
  • | • Dosing: Anaphylaxis: 0.3 to 0.5 mg IM; Cardiac Arrest: 1 mg IV q3-5min; |
  • | Shock Infusion: 0.02 to 0.3 mcg/kg/min IV. |
  • | • Actions: Powerful chronotrope, inotrope, peripheral vasoconstrictor, and bronchodilator. |
  • | |
  • | 3. VASOPRESSIN (Second-Line / Adjunct Vasopressor): |
  • | • Receptor Profile: V1 vascular receptors (++++), V2 renal receptors. |
  • | • Fixed Infusion Dose: 0.03 to 0.04 units/min IV (do not titrate). |
  • | • Actions: Non-adrenergic vasoconstriction, highly effective during profound acidosis. |
  • | • Pulmonary Vascular Sparing: Causes systemic vasoconstriction with selective pulmonary |
  • | vasodilation (lowers PVR/SVR ratio); excellent adjunct in septic shock and RV failure. |
  • | |
  • | 4. PHENYLEPHRINE (Pure Alpha-1 Vasopressor): |
  • | • Receptor Profile: Alpha-1 (+++++), Zero Beta activity. |
  • | • Dosing: Bolus: 50 to 100 mcg IV; Infusion: 0.5 to 2.0 mcg/kg/min. |
  • | • Actions: Pure systemic vasoconstriction. Can cause reflex bradycardia and reduce cardiac |
  • | output. Drug of choice for post-spinal hypotension in awake, non-shocked cesarean patients. |
  • | |
  • | 5. DOBUTAMINE (First-Line Inotrope for Pure Cardiogenic Shock): |
  • | • Receptor Profile: Beta-1 (++++), Beta-2 (++), Minimal Alpha. |
  • | • Infusion Dose: 2.5 to 20 mcg/kg/min IV. |
  • | • Actions: Increases myocardial contractility and heart rate; induces mild peripheral |
  • | vasodilation (reduces afterload). First-line inotrope for PPCM with adequate MAP. |
  • | |
  • | 6. MILRINONE (Inodilator for RV Failure & Pulmonary Hypertension): |
  • | • Mechanism: Phosphodiesterase-3 (PDE3) inhibitor. |
  • | • Infusion Dose: 0.25 to 0.75 mcg/kg/min IV (omit loading bolus). |
  • | • Actions: Increases myocardial contractility while relaxing pulmonary and systemic vascular |
  • | smooth muscle; ideal for biventricular failure with elevated PVR. Must combine with |
  • | Norepinephrine if MAP is low. |
  • +---------------------------------------------------------------------------------------------------+
  • 5. Bedside Hemodynamic Monitoring & Echocardiography (POCUS / FoCUS)

In the modern obstetric critical care unit, Point-of-Care Ultrasound (POCUS) and Focused Cardiac Ultrasound (FoCUS) provide instantaneous diagnostic clarity for undifferentiated maternal shock: +---------------------------------------------------------------------------------------------------+

  • | POCUS RAPID EVALUATION ALGORITHM IN MATERNAL SHOCK |
  • | |
  • | 1. INFERIOR VENA CAVA (IVC) COLLAPSIBILITY (Subcostal View): |
  • | • Small, Collapsible IVC (<1.5 cm diameter, >50% inspiratory collapse): |
  • | -> Indicates HYPOVOLEMIC / HEMORRHAGIC or EARLY DISTRIBUTIVE SHOCK. Responds to fluids/blood.|
  • | • Plethoric, Distended IVC (>2.1 cm diameter, <50% inspiratory collapse): |
  • | -> Indicates CARDIOGENIC or OBSTRUCTIVE SHOCK (RV failure, massive PE, tamponade). |
  • | -> CRYSTALLOID FLUID BOLUSES ARE STRICTLY CONTRAINDICATED! |
  • | |
  • | 2. LEFT VENTRICULAR (LV) CONTRACTILITY (Parasternal Long & Short Axis Views): |
  • | • Hyperdynamic LV with small end-systolic cavity (kissing papillary muscles): |
  • | -> Hypovolemic or Distributive (Septic/Anaphylactic) shock. |
  • | • Dilated, Globally Hypokinetic LV with reduced Fractional Shortening / Ejection Fraction: |
  • | -> Cardiogenic shock (PPCM, SCAD, myocarditis). |
  • | |
  • | 3. RIGHT VENTRICULAR (RV) STRAIN & INTERDEPENDENCE (Apical 4-Chamber View): |
  • | • RV Dilation (RV:LV basal diameter ratio >1.0) + Interventricular Septal Flattening (D-sign):|
  • | -> Acute Cor Pulmonale from Massive Pulmonary Embolism or Amniotic Fluid Embolism. |
  • | • McConnell's Sign: Hyperdynamic RV apex with akinesia/hypokinesia of the RV mid-free wall. |
  • | -> Highly specific for Massive Pulmonary Embolism. |
  • | |
  • | 4. PERICARDIAL SPACE EVALUATION: |
  • | • Anechoic fluid collection surrounding myocardium + Right Atrial systolic collapse / |
  • | Right Ventricular diastolic collapse: |
  • | -> CARDIAC TAMPONADE -> Perform STAT Ultrasound-Guided Pericardiocentesis! |
  • | |
  • | 5. LUNG ULTRASOUND (BLUE Protocol): |
  • | • A-lines (Horizontal artifacts) with normal lung sliding: Normal aerated lung. |
  • | • Multiple B-lines ('Lung Rockets' >=3 per intercostal space bilaterally): Alveolar-interstitial|
  • | edema (Cardiogenic pulmonary edema vs ARDS). |
  • | • Absence of Lung Sliding + Presence of 'Lung Point': PATHOGNOMONIC FOR PNEUMOTHORAX. |
  • +---------------------------------------------------------------------------------------------------+

Loading diagram... Maternal Shock Differential Diagnosis & Hemodynamic Resuscitation Algorithm